tetraethylammonium has been researched along with aspirin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apiwattanakul, N; Cha, SH; Endou, H; Kanai, Y; Nakajima, N; Sekine, T; Tsuda, M | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Dobrev, D; Francke, K; Grossmann, M; Kirch, W; Pittrow, D; Schindler, C | 1 |
3 other study(ies) available for tetraethylammonium and aspirin
| Article | Year |
|---|---|
Identification of multispecific organic anion transporter 2 expressed predominantly in the liver.
Topics: Animals; Blotting, Northern; Carrier Proteins; Ion Transport; Liver; Membrane Proteins; Organic Anion Transporters, Sodium-Independent; Rats; Salicylates; Salicylic Acid; Substrate Specificity; Xenopus laevis | 1998 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adult; Aspirin; Bisoprolol; Dose-Response Relationship, Drug; Endothelium, Vascular; Glyburide; Hand; Humans; Isoproterenol; Male; Methylene Blue; omega-N-Methylarginine; Potassium Chloride; Receptors, Adrenergic, beta-2; Tetraethylammonium; Vasodilation; Veins | 2004 |